LifeProNow

FEBRUARY 2, 2025

January 30, 2025: “The U.S. The most common adverse reactions in study participants who received Journavx were itching, muscle spasms, increased blood level of creatine phosphokinase, and rash.

Adverse Reactions 130

Adverse Reactions Labelling Drug Development 130

The Thyroid Pharmacist

MARCH 7, 2025

to fluoride in my tap water, to hidden mold in my home, to my shampoo and deodorant (have you ever read those labels?!), 16] Even more concerning, of the 133 different VOCs found across all tested products, only one, ethanol, was actually listed on any label! From indoor pollutants like formaldehyde (yes, really!),

Health and Personal Care Stores 66

Health and Personal Care Stores Labelling Immunization Immunity 66

Pharmacy Times

JUNE 12, 2025

3 The safety profile was favorable with the most common adverse effect (AE) being increased creatinine, increased potassium, dysuria, decreased hemoglobin, increased aspartate aminotransferase, increased alanine aminotransferase, increased eosinophils, decreased lymphocytes, urinary tract infection, decreased neutrophils, and hematuria.

Pharmacy Technician 26

Pharmacy Technician Biosimilars Compounding Pharmacies Pharmacy Management 26

Express Pharma

JANUARY 15, 2025

The FDA has set a Prescription Drug User Fee Act (PDUFA) action date for August 31, 2025. The BLA submission is based on data from the Clarity AD (Study 301) open-label extension (OLE) and modelling of observed data. Eisai holds final decision-making authority.

Adverse Reactions 104

Adverse Reactions Labelling Hospitals 104